Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.
Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy s...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1989
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171438/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2712546/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.1.128 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|